On 2025-05-13, Stoke Therapeutics, Inc. (STOK) announced earnings per share of $1.90 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.37.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.50 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.37 | $1.90 |
| 2025-03-18 | 2024-12-31 | $-0.51 | $-0.18 |
| 2024-11-05 | 2024-09-30 | $-0.52 | $-0.47 |
| 2024-08-07 | 2024-06-30 | $-0.57 | $-0.46 |
| 2024-05-06 | 2024-03-31 | $-0.60 | $-0.57 |
| 2024-03-25 | 2023-12-31 | $-0.62 | $-0.60 |
| 2023-11-07 | 2023-09-30 | $-0.65 | $-0.55 |
| 2023-08-07 | 2023-06-30 | $-0.65 | $-0.69 |
| 2023-05-04 | 2023-03-31 | $-0.70 | $-0.53 |
| 2023-03-06 | 2022-12-31 | $-0.72 | $-0.65 |
| 2022-11-14 | 2022-09-30 | $-0.69 | $-0.66 |
| 2022-08-08 | 2022-06-30 | $-0.70 | $-0.63 |
| 2022-05-10 | 2022-03-31 | $0.61 | $-0.66 |
| 2022-03-10 | 2021-12-31 | $-0.62 | $-0.66 |
| 2021-11-08 | 2021-09-30 | $-0.58 | $-0.61 |
| 2021-08-10 | 2021-06-30 | $-0.49 | $-0.60 |
| 2021-05-10 | 2021-03-31 | $-0.44 | $-0.46 |
| 2021-03-09 | 2020-12-31 | $-0.43 | $-0.42 |
| 2020-11-12 | 2020-09-30 | $-0.42 | $-0.41 |
| 2020-08-10 | 2020-06-30 | $-0.36 | $-0.39 |
| 2020-05-15 | 2020-03-31 | $-0.37 | $-0.34 |
| 2019-11-12 | 2019-09-30 | $-0.29 | $-0.26 |
| 2019-08-14 | 2019-06-30 | $-1.02 | $-1.54 |